Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

Long-acting muscarinic antagonists, as add-on therapy to inhaled corticosteroids, improve lung function parameters and reduce ...

Integrated Drug Discovery, Sanofi R&D, 1 rue Pierre Brossolette, Chilly Mazarin 91385, France ...

Hepatitis C virus (HCV) infection is highly associated with the development of metabolic dysfunction-associated steatotic ...

This was a retrospective analysis of electronic pharmacy and medical claims from a commercial health plan located in the states of California, Texas, Oklahoma, Oregon, and Washington, with annual ...

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 collaboration between GSK and Theravance, in which Theravance handed over its ...

Treatments were administered subcutaneously and added to double therapy (inhaled corticosteroid [ICS] plus long-acting beta2-agonist [LABA] or long-acting muscarinic antagonist [LAMA] plus LABA ...

Treatments were administered subcutaneously and added to double therapy (inhaled corticosteroid [ICS] plus long-acting beta2-agonist [LABA] or long-acting muscarinic antagonist [LAMA] plus LABA) or a ...

Treatments were administered subcutaneously and added to double therapy (inhaled corticosteroid [ICS] plus long-acting beta2-agonist [LABA] or long-acting muscarinic antagonist [LAMA] plus LABA) or a ...

View all available purchase options and get full access to this article.

USA: A large-scale US-based study has found that long-acting lipoglycopeptides (laLGPs), including dalbavancin and oritavancin, are as effective as standard-of-care (SOC) antibiotics in the step-down ...